Suppr超能文献

细支气管肺泡癌:一项临床与细胞学相关研究。

Bronchiolo-alveolar carcinoma: a correlative clinical and cytologic study.

作者信息

Tao L C, Delarue N C, Sanders D, Weisbrod G

出版信息

Cancer. 1978 Dec;42(6):2759-67. doi: 10.1002/1097-0142(197812)42:6<2759::aid-cncr2820420635>3.0.co;2-#.

Abstract

From 1970 to 1977, 101 patients with bronchiolo-alveolar carcinoma were admitted to the Toronto General Hospital. Cytology preparations from 97 patients were reviewed and analyzed in correlation with biologic behavior of the tumours. The value of cytologic diagnosis was reassessed. It appears that routine cytology methods were of limited value in the investigation of patients with a peripheral solitary tumor and therefore, percutaneous fine needle aspiration with positive results in 92% of cases examined, was the only useful cytologic examination for this type of lesion. For multicentric tumors, routine cytology methods achieved positive results in 87.9% of cases and fine needle aspiration 100%. Based on cytomorphologic features, bronchioloalveolar carcinoma can be subclassified into three types: secretory, nonsecretory and poorly differentiated. In this series, 84% of solitary tumors were secretory or nonsecretory type with favorable prognosis, and 16% of solitary tumors were poorly differentiated type with poor prognosis. 55.2% of multicentric tumors were poorly differentiated type and 77.3% of multicentric tumors showed positive lymph nodes at surgery. Our results demonstrate that patients with multicentric or poorly differentiated tumors had poor prognosis.

摘要

1970年至1977年期间,101例细支气管肺泡癌患者入住多伦多综合医院。对97例患者的细胞学标本进行回顾性分析,并与肿瘤的生物学行为进行关联分析。重新评估了细胞学诊断的价值。结果显示,常规细胞学方法在周围型孤立性肿瘤患者的检查中价值有限,因此,经皮细针穿刺活检在92%的检查病例中取得阳性结果,是此类病变唯一有用的细胞学检查方法。对于多中心性肿瘤,常规细胞学方法在87.9%的病例中取得阳性结果,细针穿刺活检则为100%。根据细胞形态学特征,细支气管肺泡癌可分为三种类型:分泌型、非分泌型和低分化型。在本系列研究中,84%的孤立性肿瘤为分泌型或非分泌型,预后良好,16%的孤立性肿瘤为低分化型,预后较差。55.2%的多中心性肿瘤为低分化型,77.3%的多中心性肿瘤在手术时出现淋巴结转移。我们的研究结果表明,多中心性或低分化型肿瘤患者预后较差。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验